Ophthalmology Times Newsletter

To view this email as a web page, click here.

Greater IOP-lowering potential with iStent inject

The number of glaucoma sufferers rises every year, as has the advent of new technology with which to treat this disease, according to Joseph Gira, MD.

Find out

(WATCH) Subretinal fluid may help eyes with wet nAMD

According to results from the Harbor Trial, persistent subretinal fluid fared better with visual acuity than subfoveal neovascular age-related macular degeneration (nAMD) eyes that were dry. Nancy M. Holekamp, MD, discusses how this could impact future treatment decisions.

Test your knowledge

Three secrets to success for low myopes

Low to moderate myopes are among the most challenging patients to satisfy with cataract surgery, according to Cynthia Matossian, MD. Here are three ways to set their expectations prior to surgery.

Learn more

Excellent visual outcomes achieved with novel trifocal design

(SLIDESHOW) 7 pediatric eye myths parents should stop believing

Dislocation and decentration remain common reasons for IOL removal

FDA approves aflibercept prefilled syringe injection

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.